The KM of PFI analysis showed that DDR1 was a protective factor for patients with PCPG and UVM, and Cox regression analysis showed that DDR1 was a protective factor in BLCA, KICH, KIRC, KIRP, and UVM (Fig. 5C–E). Here, DDR1 is linked to bladder transitional cell carcinoma.